Molecular Biometrics
Norwood
About Molecular Biometrics
Molecular Biometrics, Inc., is applying novel metabolomic technologies to develop accurate, non-invasive methodologies for evaluating normal biologic function in health and disease, and for drug discovery and development. The company's proprietary technology is being applied in reproductive health, neurodegenerative disease (Alzheimer's disease and Parkinson's disease), maternal fetal medicine, pulmonary metabolism and edema, and lactate metabolism.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $24.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2010)
- Website: molecularbiometrics.com
- Phone: 781-501-5600
Industries & Categories
Biotechnology, Health Care, Medical Device
Canonical: https://fsome.com/organization/molecular-biometrics-2762221 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.